KSA
ALXN
Ken Stern & Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $306K | Hold |
2,200
| – | – | 0.13% | 100 |
|
|
2018
Q2 | $273K | Hold |
2,200
| – | – | 0.13% | 101 |
|
|
2018
Q1 | $245K | Hold |
2,200
| – | – | 0.11% | 107 |
|
|
2017
Q4 | $263K | Sell |
2,200
-500
| -19% | -$59.8K | 0.11% | 98 |
|
|
2017
Q3 | $380K | Hold |
2,700
| – | – | 0.17% | 68 |
|
|
2017
Q2 | $330K | Sell |
2,700
-500
| -16% | -$61.1K | 0.15% | 77 |
|
|
2017
Q1 | $409K | Hold |
3,200
| – | – | 0.19% | 67 |
|
|
2016
Q4 | $392K | Buy |
+3,200
| New | +$392K | 0.2% | 73 |
|